Sage Therapeutics Inc

NASDAQ: SAGE
$4.85
-$0.06 (-1.2%)
Closing Price on November 21, 2024

SAGE Stock Chart and Intraday Price

SAGE Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 215 FIRST STREET, CAMBRIDGE, MA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 1,313.93M USD
Shares Outstanding 60,107,000
Sage Therapeutics Inc is a biopharmaceutical company focused on innovating brain health medicines. It has developed ZULRESSO, a treatment for postpartum depression, and is working on other promising drugs like ZURZUVAE for the same condition, SAGE-324 for essential tremors, and SAGE-718 aimed at various neurological disorders including depression and Alzheimer's disease. The company collaborates with global partners like Shionogi & Co. and Biogen MA Inc. to expand its reach. Founded in 2010 and based in Cambridge, Massachusetts, Sage Therapeutics is committed to addressing unmet needs in brain health.

SAGE Articles

Wednesday's top analyst upgrades and downgrades included Amazon.com, Beyond Meat, Compass, DraftKings, Genius Sports, Home Depot, International Flavors & Fragrances, Lowe's, Palantir Technologies,...
Tuesday's top analyst upgrades and downgrades included Cloudflare, Datadog, Dish Network, DraftKings, Fortinet, MGM Resorts, PG&E, Rocket Companies, Southwest Airlines, United Airlines, Wayfair and...
Tuesday's top analyst upgrades and downgrades included Ally Financial, Amgen, Baidu, Bilibili, Bill.com, Coinbase Global, Eli Lilly, GE Healthcare Technologies, JPMorgan Chase, Merck, Moderna,...
Thursday's top analyst upgrades and downgrades included Analog Devices, Eli Lilly, Fastenal, Global Payments, Keurig Dr Pepper, Lululemon Athletica, Merck, Occidental Petroleum, Rivian Automotive and...
Friday's top analyst upgrades and downgrades included Amgen, Bank of New York Mellon, Block, Consolidated Edison, Dell Technologies, Exxon Mobil, Flex, GameStop, Huntsman, Lockheed Martin,...
Tuesday afternoon's analyst upgrades and downgrades included Esports Entertainment, Expedia, Ford, ON Semiconductor, Salesforce and more.
Thursday afternoon's analyst upgrades and downgrades included Amazon, Bank of America, BioNTech, Chipotle, Disney and more.
Wednesday's top analyst upgrades and downgrades included AbbVie, Alcoa, Anheuser Busch, Applied Materials, CyberArk, Fox, Merck, Paychex, ViacomCBS and Waste Management.
Friday's top analyst upgrades and downgrades included AIG, Best Buy, Carvana, Dell Technologies, HP, L Brands, Monster Beverage, Twitter and Zscaler.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including AT&T, Expedia, Mattel and Urban Outfitters.
Tuesday's top analyst upgrades and downgrades included Avaya, Dell Technologies, On Semiconductor, Neurocrine Biosciences, Palo Alto Networks, Ping Identity, Poshmark and Switch.
Friday's top analyst upgrades and downgrades included Adobe, Ford, Goldman Sachs, Intel, Microsoft, Salesforce.com, Seagate Technology, Snowflake, Targa Resources and Walt Disney.
Friday's top analyst upgrades and downgrades included Ally Financial, Boeing, Cracker Barrel Old Country Store, Dish Network, FedEx, Marvell Technology, Prudential, Stitch Fix and Teladoc Health.
Canaccord Genuity recently released a report detailing some of the biggest biotech catalysts coming out over these next six months.
Wednesday's top analyst upgrades, downgrades and initiations included American Express, Boeing, Caterpillar, Lennar, Simon Property, Sirius XM, Six Flags, Tesla, Walmart and Zynga.